Sionna Therapeutics (SION) PT Raised to $55 at Stifel On Optimism about ph2a data
Tweet Send to a Friend
Stifel analyst Paul Matteis raised the price target on Sionna Therapeutics (NASDAQ: SION) to $55.00 (from $44.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
